Massive pulmonary embolism: Review of management strategies with a focus on catheter-based techniques

Expert Review of Cardiovascular Therapy

Volumn 8, Issue 6, 2010, Pages 863-873

  Lee, Licheng ^a   Kavinsky, Clifford J ^b   Spies, Christian ^a,c  

^a UNIVERSITY OF HAWAII   (United States)

^b RUSH UNIVERSITY   (United States)

^c QUEEN S MEDICAL CENTER   (United States)

Author keywords

Catheter embolectomy; Catheter extraction or fragmentation; Fibrinolysis; Percutaneous devices; Percutaneous mechanical thrombectomy; Pulmonary embolism; Surgical embolectomy; Thrombolysis; Thrombolytic therapy

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; HEPARIN; STREPTOKINASE; UROKINASE;

BLEEDING; BRADYCARDIA; CLINICAL TRIAL; DISEASE SEVERITY; DRUG MEGADOSE; EMBOLECTOMY; FIBRINOLYSIS; HUMAN; LUNG EMBOLISM; PERCUTANEOUS THROMBECTOMY; PERFORATION; REVIEW; RHEOLYTIC THROMBECTOMY; RISK FACTOR; THROMBOGENESIS; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME; TREATMENT PLANNING; ALGORITHM; CARDIOGENIC SHOCK; CATHETERIZATION; COMPARATIVE STUDY; CONTRAINDICATIONS; FIBRINOLYTIC THERAPY; HYPOTENSION; PATHOLOGY; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PROGNOSIS; PULMONARY ARTERY; PULMONARY EMBOLISM; SEVERITY OF ILLNESS INDEX; SURGERY; THROMBECTOMY;

ALGORITHMS; CATHETERIZATION; EMBOLECTOMY; FIBRINOLYTIC AGENTS; HUMANS; HYPOTENSION; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; PULMONARY ARTERY; PULMONARY EMBOLISM; SEVERITY OF ILLNESS INDEX; SHOCK, CARDIOGENIC; THROMBECTOMY; THROMBOLYTIC THERAPY;

EID: 77953514791     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.10.52     Document Type: Review

References (71)

1. Wood KE. Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest 121(3), 877-905 (2002).
2. Kucher N, Goldhaber SZ. Management of massive pulmonary embolism. Circulation 112(2), e28-e32 (2005).
3. Kucher N, Rossi E, De Rosa M, Goldhaber SZ. Massive pulmonary embolism. Circulation 113(4), 577-582 (2006).
4. Torbicki A, Perrier A, Konstantinides S et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur. Heart J. 29(18), 2276-2315 (2008).
5. Kasper W, Konstantinides S, Geibel A et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J. Am. Coll. Cardiol 30(5), 1165-1171 (1997).
6. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 353(9162), 1386-1389 (1999).
7. Tibbutt DA, Davies JA, Anderson JA et al. Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonary embolism Br. Med. J. 1, 343-347 (1974).
8. Ly B, Arnesen H, Eie H, Hol R. A controlled clinical trial of streptokinase and heparin in the treatment of major pulmonary embolism. Acta Med. Scand. 203(6), 465-470 (1978). (Pubitemid 8358211)
9. Dotter CT, Seaman AJ, Rosch J et al. Streptokinase and heparin in the treatment of pulmonary embolism: a randomized comparison. Vasc. Surg. 13, 42-52 (1979).
10. Jerjes-Sanchez C, Ramirez-Rivera A, de Lourdes Garcia M et al. Streptokinase and heparin versus heparin alone in massive pulmonary embolism: a randomized controlled trial. J. Thromb. Thrombolysis 2(3), 227-229 (1995).
11. The urokinase pulmonary embolism trial. A national cooperative study. Circulation 47(Suppl. II), II-1 (1973).
12. Marini C, Di Ricco G, Rossi G, Rindi M, Palla R, Giuntini C. Fibrinolytic effects of urokinase and heparin in acute pulmonary embolism: a randomized clinical trial. Respiration 54(3), 162-173 (1988).
13. Dalla-Volta S, Palla A, Santolicandro A et al. PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. J. Am. Coll. Cardiol. 20(3), 520-526 (1992).
14. Goldhaber SZ, Haire WD, Feldstein ML et al. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet 341(8844), 507-511 (1993).
15. Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N. Engl. J. Med. 347(15), 1143-1150 (2002).
16. Levine M, Hirsh J, Weitz J et al. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Chest 98(6), 1473-1479 (1990).
17. Tissue plasminogen activator for the treatment of acute pulmonary embolism. A collaborative study by the PIOPED Investigators. Chest 97(3), 528-533 (1990).
18. Arcasoy SM, Kreit JW. Thrombolytic therapy of pulmonary embolism: a comprehensive review of current evidence. Chest 115(6), 1695-1707 (1999).
19. Goldhaber SZ. Thrombolysis in pulmonary embolism: a large-scale clinical trial is overdue. Circulation 104(24), 2876-2878 (2001).
20. Thabut G, Thabut D, Myers RP et al. Thrombolytic therapy of pulmonary embolism: a meta-analysis. J. Am. Coll. Cardiol. 40(9), 1660-1667 (2002).
21. Wan S, Quinlan DJ, Agnelli G, Eikelboom JW. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. Circulation 110(6), 744-749 (2004).
22. Agnelli G, Becattini C, Kirschstein T. Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcome-based meta-analysis. Arch. Intern. Med. 162(22), 2537-2541 (2002).
23. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133(Suppl. 6), 454S-545S (2008). (Pubitemid 351892971)
24. Urokinase-streptokinase embolism trial. Phase 2 results. A cooperative study. JAMA 229(12), 1606-1613 (1974).
25. Goldhaber SZ, Agnelli G, Levine MN. Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. The Bolus Alteplase Pulmonary Embolism Group. Chest 106(3), 718-724 (1994).
26. Goldhaber SZ, Kessler CM, Heit J et al. Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism. Lancet 2(8606), 293-298 (1988).
27. Goldhaber SZ, Kessler CM, Heit JA et al. Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial. J. Am. Coll. Cardiol. 20(1), 24-30 (1992).
28. Meneveau N, Schiele F, Metz D et al. Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: immediate clinical and hemodynamic outcome and one-year follow-up. J. Am. Coll. Cardiol. 31(5), 1057-1063 (1998). (Pubitemid 28212506)
29. Meneveau N, Schiele F, Vuillemenot A et al. Streptokinase vs alteplase in massive pulmonary embolism. A randomized trial assessing right heart haemodynamics and pulmonary vascular obstruction. Eur. Heart J. 18(7), 1141-1148 (1997).
30. Meyer G, Sors H, Charbonnier B et al. Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: a European multicenter double-blind trial. The European Cooperative Study Group for Pulmonary Embolism. J. Am. Coll. Cardiol. 19(2), 239-245 (1992).
31. Sors H, Pacouret G, Azarian R, Meyer G, Charbonnier B, Simonneau G. Hemodynamic effects of bolus vs 2-h infusion of alteplase in acute massive pulmonary embolism. A randomized controlled multicenter trial. Chest 106(3), 712-717 (1994).
32. Verstraete M, Miller GA, Bounameaux H et al. Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism. Circulation 77(2), 353-360 (1988). (Pubitemid 18060044)
33. Guyatt GH, Cook DJ, Jaeschke R, Pauker SG, Schunemann HJ. Grades of recommendation for antithrombotic agents: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133(Suppl. 6), 123S-131S (2008).
34. Aklog L, Williams CS, Byrne JG, Goldhaber SZ. Acute pulmonary embolectomy: a contemporary approach. Circulation 105(12), 1416-1419 (2002).
35. Doerge HC, Schoendube FA, Loeser H, Walter M, Messmer BJ. Pulmonary embolectomy: review of a 15-year experience and role in the age of thrombolytic therapy. Eur. J. Cardiothorac. Surg. 10(11), 952-957 (1996).
36. Meneveau N, Seronde MF, Blonde MC et al. Management of unsuccessful thrombolysis in acute massive pulmonary embolism. Chest 129(4), 1043-1050 (2006).
37. Stein PD, Alnas M, Beemath A, Patel NR. Outcome of pulmonary embolectomy. Am. J. Cardiol. 99(3), 421-423 (2007).
38. Suarez JA, Meyerrose GE, Phisitkul S et al. Review of catheter thrombectomy devices. Cardiology 102(1), 11-15 (2004).
39. Kucher N. Catheter embolectomy for acute pulmonary embolism. Chest 132(2), 657-663 (2007).
40. Uflacker R. Interventional therapy for pulmonary embolism. J. Vasc. Interv. Radiol. 12(2), 147-164 (2001).
41. Schmitz-Rode T, Janssens U, Schild HH, Basche S, Hanrath P, Gunther RW. Fragmentation of massive pulmonary embolism using a pigtail rotation catheter. Chest 114(5), 1427-1436 (1998).
42. Schmitz-Rode T, Janssens U, Duda SH, Erley CM, Gunther RW. Massive pulmonary embolism: percutaneous emergency treatment by pigtail rotation catheter. J. Am. Coll. Cardiol. 36(2), 375-380 (2000).
43. Tajima H, Murata S, Kumazaki T et al. Hybrid treatment of acute massive pulmonary thromboembolism: mechanical fragmentation with a modified rotating pigtail catheter, local fibrinolytic therapy, and clot aspiration followed by systemic fibrinolytic therapy. AJR Am. J. Roentgenol. 183(3), 589-595 (2004).
44. Barbosa MA, Oliveira DC, Barbosa AT et al. Treatment of massive pulmonary embolism by percutaneous fragmentation of the thrombus. Arq. Bras. Cardiol. 88(3), 279-284 (2007).
45. De Gregorio MA, Gimeno MJ, Mainar A et al. Mechanical and enzymatic thrombolysis for massive pulmonary embolism. J. Vasc. Interv. Radiol. 13(2 Pt 1), 163-169 (2002).
46. Pieri S, Agresti P. Hybrid treatment with angiographic catheter in massive pulmonary embolism: mechanical fragmentation and fibrinolysis. Radiol. Med. 112(6), 837-849 (2007).
47. Spies C, Khandelwal A, Smith TH, Jolly N, Kavinsky CJ. Percutaneous mechanical thrombectomy for massive pulmonary embolism using a conservative treatment strategy. J. Interv. Cardiol. 21(6), 566-571 (2008).
48. Chauhan MS, Kawamura A. Percutaneous rheolytic thrombectomy for large pulmonary embolism: a promising treatment option. Catheter. Cardiovasc. Interv. 70(1), 121-128 (2007).
49. Margheri M, Vittori G, Vecchio S et al. Early and long-term clinical results of AngioJet rheolytic thrombectomy in patients with acute pulmonary embolism. Am. J. Cardiol. 101(2), 252-258 (2008).
50. Biederer J, Schoene A, Reuter M, Heller M, Muller-Hulsbeck S. Suspected pulmonary artery disruption after transvenous pulmonary embolectomy using a hydrodynamic thrombectomy device: clinical case and experimental study on porcine lung explants. J. Endovasc. Ther. 10(1), 99-110 (2003).
51. Voigtlander T, Rupprecht HJ, Nowak B et al. Clinical application of a new rheolytic thrombectomy catheter system for massive pulmonary embolism. Catheter Cardiovasc. Interv. 47(1), 91-96 (1999).
52. Sur JP, Garg RK, Jolly N. Rheolytic percutaneous thrombectomy for acute pulmonary embolism in a pediatric patient. Catheter. Cardiovasc. Interv. 70(3), 450-453 (2007).
53. Brahmbhatt T, Tutton S, Mannebach P, Cinquegrani M. Rheolytic thrombectomy in patient with massive pulmonary embolism: a case report and review of literature. Catheter. Cardiovasc. Interv. 70(6), 802-806 (2007).
54. Myat A, Ahsan A. Percutaneous mechanical thrombectomy for the treatment of acute massive pulmonary embolism: case report. Thromb. J. 5(1), 20 (2007).
55. Chiam P, Kwok V, Johan BA, Chan C. Major pulmonary embolism treated with a rheolytic thrombectomy catheter. Singapore Med. J. 46(9), 479-482 (2005).
56. Speciale G, Pelliccia F, Vitalone V, Segneri M, Valentini P, Richichi G. A case of massive pulmonary embolism treated with AngioJet thrombectomy system. Ital. Heart J. Suppl. 6(5), 302-305 (2005).
57. Feldman JP, Feinstein JA, Lamberti JJ, Perry SB. AngioJet catheter-based thrombectomy in a neonate with postoperative pulmonary embolism. Catheter. Cardiovasc. Interv. 66(3), 442-445 (2005).
58. Brenes JC, Ferreira A, Galindo A. A pulmonary embolism treated with the AngioJet technique in a patient with double outlet right ventricle. J. Invasive Cardiol. 16(1), 42-44 (2004).
59. Dwarka D, Schwartz SA, Smyth SH, O'Brien MJ. Bradyarrhythmias during use of the AngioJet system. J. Vasc. Interv. Radiol. 17(10), 1693-1695 (2006).
60. Blaustein HS, Schur I, Shapiro JM. Acute massive pulmonary embolism in a Jehovah's witness: successful treatment with catheter thrombectomy. Chest 117(2), 594-597 (2000).
61. Koning R, Cribier A, Gerber L et al. A new treatment for severe pulmonary embolism: percutaneous rheolytic thrombectomy. Circulation 96(8), 2498-2500 (1997).
62. Zeni PT Jr, Blank BG, Peeler DW. Use of rheolytic thrombectomy in treatment of acute massive pulmonary embolism. J. Vasc. Interv. Radiol. 14(12), 1511-1515 (2003).
63. Iskander A, Nayak A, Chauhan MS. Submassive pulmonary embolism and paradoxical embolic stroke treated with percutaneous rheolytic thrombectomy and closure of the patent foramen ovale. Catheter. Cardiovasc. Interv. 64(3), 356-360 (2005).
64. Siablis D, Karnabatidis D, Katsanos K, Kagadis GC, Zabakis P, Hahalis G. AngioJet rheolytic thrombectomy versus local intrapulmonary thrombolysis in massive pulmonary embolism: a retrospective data analysis. J. Endovasc. Ther. 12(2), 206-214 (2005).
65. Vincent RN, Dinkins J, Dobbs MC. Mechanical thrombectomy using the AngioJect in a child with congenital heart disease. Catheter. Cardiovasc. Interv. 61(2), 253-255 (2004).
66. Garg RK, Jolly N. Percutaneous thrombectomy for pulmonary embolism. J. Invasive Cardiol. 18(12), 640 (2006).
67. Skaf E, Beemath A, Siddiqui T, Janjua M, Patel NR, Stein PD. Catheter-tip embolectomy in the management of acute massive pulmonary embolism. Am. J. Cardiol. 99(3), 415-420 (2007).
68. Margheri M, Falai M, Vittori G et al. Safety and efficacy of the AngioJet in patients with acute myocardial infarction: results from the Florence Appraisal Study of Rheolytic Thrombectomy (FAST). J. Invasive Cardiol. 18(10), 481-486 (2006).
69. Vecchio S, Vittori G, Chechi T et al. Percutaneous rheolytic thrombectomy with AngioJet for pulmonary embolism: methods and results in the experience of a high-volume center. G. Ital. Cardiol. (Rome) 9(5), 355-363 (2008).
70. Kuo WT, Gould MK, Louie JD, Rosenberg JK, Sze DY, Hofmann LV. Catheter-directed therapy for the treatment of massive pulmonary embolism: systematic review and meta-analysis of modern techniques. J. Vasc. Interv. Radiol. 20(11), 1431-1440 (2009).
71. Goldhaber SZ. Percutaneous mechanical thrombectomy for acute pulmonary embolism: a double-edged sword. Chest 132(2), 363-365 (2007).